Taylor & Francis Group

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Tallman
    Tallman
  4. Horwitz
    Horwitz
  5. Hassoun
    Hassoun
  6. Landau
    Landau
  7. Yahalom
    Yahalom
  8. Devlin
    Devlin
  9. Hay
    Hay
  10. Banerjee
    Banerjee

Groups

  1. Department of Medicine (383)
  2. Hematologic Malignancies, Division of (275)
  3. Center for Hematologic Malignancies (266)
  4. Survivorship Research (172)
  5. Population Sciences Research Program (133)
  6. Psychiatry and Behavioral Sciences, Department of (115)
  7. GSK Faculty (104)
  8. Solid Tumor Oncology Division (91)
  9. Lymphoma (89)
  10. Adult Leukemia (86)
Search Within
Formats
  1. Journal Article (774)
  2. Book Section (62)
  3. Review (59)
  4. Meeting Abstract (41)
  5. Editorial (20)
  6. Research Letter (17)
  7. Correspondence (10)
  8. Conference Paper (9)
  9. Book Whole (4)
  10. Guidelines (2)
Groups
  1. Department of Medicine (383)
  2. Hematologic Malignancies, Division of (275)
  3. Center for Hematologic Malignancies (266)
  4. Survivorship Research (172)
  5. Population Sciences Research Program (133)
  6. Psychiatry and Behavioral Sciences, Department of (115)

More Groups

People
  1. Sergio Giralt (35)
  2. Andrew Zelenetz (30)
  3. Martin Tallman (28)
  4. Philip Bialer (22)
  5. Steven Horwitz (22)
  6. Hani Hassoun (21)

More People

Years
  1. 2025 (22)
  2. 2024 (45)
  3. 2023 (39)
  4. 2022 (51)
  5. 2021 (45)
  6. 2020 (54)

More Years

Publications
  1. Leukemia and Lymphoma (307)
  2. Expert Review of Anticancer Therapy (68)
  3. Journal of Psychosocial Oncology (58)
  4. Women's Oncology Review (35)
  5. Cancer Biology and Therapy (28)
  6. Atlas of Procedures in Breast Cancer Surgery (24)

More Publications

Results (998)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Point-of-care CAR T-cell therapy as salvage strategy for out-of-specification tisagenlecleucel
    Journal Article

    Fried, S.; Shouval, R.; Varda-Bloom, N.; Besser, M. J.; Yerushalmi, R.; Shem-Tov, N.; Danylesko, I.; Jacoby, E.; Teihman, S.; Itzhaki, O.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy
    Correspondence

    Nath, K.; Shekarkhand, T.; Salcedo, M.; Derkach, A.; Rueda, S.; Chansakul, A.; Hulcrantz, M.; Korde, N.; Shah, U. A.; Tan, C.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Biochemical measures of ovarian function in female survivors of retinoblastoma treated with intra-arterial melphalan: An initial report
    Journal Article

    Marathe, P. H.; Dunkel, I. J.; Francis, J. H.; Antal, Z.; Gobin, Y. P.; Abramson, D. H.; Friedman, D. N.
    Ophthalmic Genetics (2022)

    Fulltext@MSK | Save
  • Development of a distributed international patient data registry for hairy cell leukemia
    Review

    Andritsos, L. A.; Anghelina, M.; Neal, J.; Blachly, J. S.; Mathur, P.; Lele, O.; Dearden, C.; Iyengar, S.; Cross, M.; Zent, C. S.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Successful brentuximab vedotin and nivolumab therapy of multiply refractory diffuse large B-cell lymphoma with Hodgkin features
    Correspondence

    Zibara, V.; Sen, F.; Scordo, M.; Falchi, L.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: A phase II risk-adapted design
    Journal Article

    Kumar, A.; Casulo, C.; Joffe, E.; Moskowitz, C.; Gerecitano, J.; Moskowitz, A.; Younes, A.; Drullinsky, P.; Drill, E.; Choma, M.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Prognostic value of minimal residual disease among patients with classical Hodgkin lymphoma undergoing autologous stem cell transplantation
    Journal Article

    Taranto, E.; Redd, R.; Jeter, E.; McHugh, K.; Crombie, J. L.; Fisher, D. C.; Jacobsen, E.; Jacobson, C. A.; Kim, A. I.; LaCasce, A. S.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • An opportunity to increase human papillomavirus vaccination rates: Change the guidelines
    Journal Article

    Aragones, A.; Gany, F.; Kaplan, A.; Bruno, D.
    Human Vaccines & Immunotherapeutics (2022)

    Fulltext@MSK | Save
  • Next-generation immunotherapy for solid tumors: Combination immunotherapy with crosstalk blockade of TGFβ and PD-1/PD-L1
    Review

    Quach, H. T.; Hou, Z.; Bellis, R. Y.; Saini, J. K.; Amador-Molina, A.; Adusumilli, P. S.; Xiong, Y.
    Expert Opinion on Investigational Drugs (2022)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab combination therapy for adult patients with advanced renal cell carcinoma
    Review

    Ged, Y.; Lee, C. H.
    Expert Review of Anticancer Therapy (2022)

    Fulltext@MSK | Save